Imported Disease Annotations - OMIM |
|
Imported Disease Annotations - OMIM |
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | KEGG Annotation Import Pipeline | Pipeline to import KEGG annotations from KEGG into RGD |
2. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:3785200 | PMID:12477932 | PMID:14702039 | PMID:15691386 | PMID:15698476 | PMID:15851850 | PMID:16189514 | PMID:16344560 | PMID:17207965 | PMID:18029348 | PMID:19322201 | PMID:21145461 |
PMID:21167302 | PMID:21630459 | PMID:21873635 | PMID:21942715 | PMID:23246001 | PMID:23314748 | PMID:23463506 | PMID:23826228 | PMID:24244333 | PMID:26344197 | PMID:27129302 | PMID:27432908 |
PMID:28117675 | PMID:29051577 | PMID:30575818 | PMID:33838681 |
TUBA3D (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tuba3b (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tuba3b (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOC608051 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOC100510930 (Sus scrofa - pig) |
|
.
Variants in TUBA3D
28 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh37/hg19 2q21.1(chr2:132140614-132312325)x3 | copy number gain | VATER association [RCV000519182] | Chr2:132140614..132312325 [GRCh37] Chr2:2q21.1 |
likely benign |
GRCh38/hg38 2q14.1-21.3(chr2:118086324-134964738)x1 | copy number loss | See cases [RCV000054058] | Chr2:118086324..134964738 [GRCh38] Chr2:118843900..135722308 [GRCh37] Chr2:118560370..135438778 [NCBI36] Chr2:2q14.1-21.3 |
pathogenic |
NM_080386.3(TUBA3D):c.1107C>G (p.Ala369=) | single nucleotide variant | Malignant melanoma [RCV000065068] | Chr2:131482602 [GRCh38] Chr2:132240175 [GRCh37] Chr2:131956645 [NCBI36] Chr2:2q21.1 |
not provided |
GRCh38/hg38 2q21.1(chr2:131310498-131508954)x3 | copy number gain | See cases [RCV000135111] | Chr2:131310498..131508954 [GRCh38] Chr2:132068071..132266527 [GRCh37] Chr2:131784541..131982997 [NCBI36] Chr2:2q21.1 |
benign |
GRCh38/hg38 2q21.1(chr2:130743933-131549753)x1 | copy number loss | See cases [RCV000137130] | Chr2:130743933..131549753 [GRCh38] Chr2:131501506..132307326 [GRCh37] Chr2:131217976..132023796 [NCBI36] Chr2:2q21.1 |
likely pathogenic|uncertain significance |
GRCh38/hg38 2q14.3-22.1(chr2:123445762-140592538)x1 | copy number loss | See cases [RCV000136714] | Chr2:123445762..140592538 [GRCh38] Chr2:124203338..141350107 [GRCh37] Chr2:123919808..141066577 [NCBI36] Chr2:2q14.3-22.1 |
pathogenic |
GRCh38/hg38 2q21.1(chr2:131337384-131605323)x1 | copy number loss | See cases [RCV000139227] | Chr2:131337384..131605323 [GRCh38] Chr2:132094957..132362896 [GRCh37] Chr2:131811427..132079366 [NCBI36] Chr2:2q21.1 |
likely benign|uncertain significance |
GRCh38/hg38 2q21.1-21.2(chr2:131451345-131736366)x3 | copy number gain | See cases [RCV000139297] | Chr2:131451345..131736366 [GRCh38] Chr2:132208918..132493939 [GRCh37] Chr2:131925388..132210409 [NCBI36] Chr2:2q21.1-21.2 |
likely benign |
GRCh38/hg38 2q21.1-21.2(chr2:131451345-131736366)x1 | copy number loss | See cases [RCV000139301] | Chr2:131451345..131736366 [GRCh38] Chr2:132208918..132493939 [GRCh37] Chr2:131925388..132210409 [NCBI36] Chr2:2q21.1-21.2 |
likely benign |
GRCh38/hg38 2q21.1-21.2(chr2:131409034-131940119)x1 | copy number loss | See cases [RCV000139880] | Chr2:131409034..131940119 [GRCh38] Chr2:132166607..132697692 [GRCh37] Chr2:131883077..132414162 [NCBI36] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh38/hg38 2q21.1(chr2:131340404-131643336)x1 | copy number loss | See cases [RCV000139536] | Chr2:131340404..131643336 [GRCh38] Chr2:132097977..132400909 [GRCh37] Chr2:131814447..132117379 [NCBI36] Chr2:2q21.1 |
likely benign |
GRCh38/hg38 2q21.1(chr2:131337384-131619715)x1 | copy number loss | See cases [RCV000140823] | Chr2:131337384..131619715 [GRCh38] Chr2:132094957..132377288 [GRCh37] Chr2:131811427..132093758 [NCBI36] Chr2:2q21.1 |
likely benign|uncertain significance |
GRCh38/hg38 2q21.1(chr2:131271331-131497222)x0 | copy number loss | See cases [RCV000141774] | Chr2:131271331..131497222 [GRCh38] Chr2:132028904..132254795 [GRCh37] Chr2:131745374..131971265 [NCBI36] Chr2:2q21.1 |
likely benign |
GRCh38/hg38 2q21.1-21.2(chr2:131100857-132436431)x3 | copy number gain | See cases [RCV000141447] | Chr2:131100857..132436431 [GRCh38] Chr2:131858430..133194004 [GRCh37] Chr2:131574900..132910474 [NCBI36] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh38/hg38 2q21.1-21.2(chr2:131291207-132406186)x3 | copy number gain | See cases [RCV000142215] | Chr2:131291207..132406186 [GRCh38] Chr2:132048780..133163759 [GRCh37] Chr2:131765250..132880229 [NCBI36] Chr2:2q21.1-21.2 |
likely benign|uncertain significance |
NM_080386.4(TUBA3D):c.31C>T (p.Gln11Ter) | single nucleotide variant | Keratoconus 9 [RCV000606401] | Chr2:131478191 [GRCh38] Chr2:132235764 [GRCh37] Chr2:2q21.1 |
pathogenic |
NM_080386.4(TUBA3D):c.200_201dup (p.Val68fs) | duplication | Keratoconus 9 [RCV000613508] | Chr2:131478358..131478359 [GRCh38] Chr2:132235931..132235932 [GRCh37] Chr2:2q21.1 |
pathogenic |
GRCh37/hg19 2q21.1(chr2:131477746-132280823)x1 | copy number loss | See cases [RCV000447366] | Chr2:131477746..132280823 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1(chr2:132238316-132290940)x3 | copy number gain | See cases [RCV000446059] | Chr2:132238316..132290940 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q14.3-22.1(chr2:128490257-138210164)x1 | copy number loss | See cases [RCV000445892] | Chr2:128490257..138210164 [GRCh37] Chr2:2q14.3-22.1 |
pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384) | copy number gain | See cases [RCV000512056] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q21.1-21.2(chr2:130920847-134220436)x3 | copy number gain | See cases [RCV000511730] | Chr2:130920847..134220436 [GRCh37] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3 | copy number gain | See cases [RCV000511212] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
NM_080386.4(TUBA3D):c.989C>T (p.Ala330Val) | single nucleotide variant | Inborn genetic diseases [RCV003296018] | Chr2:131480682 [GRCh38] Chr2:132238255 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q12.1-24.3(chr2:104172062-168223828)x1 | copy number loss | Poly (ADP-Ribose) polymerase inhibitor response [RCV000626436] | Chr2:104172062..168223828 [GRCh37] Chr2:2q12.1-24.3 |
drug response |
GRCh37/hg19 2q14.2-22.1(chr2:120571363-141627287)x1 | copy number loss | See cases [RCV000512348] | Chr2:120571363..141627287 [GRCh37] Chr2:2q14.2-22.1 |
pathogenic |
Single allele | deletion | not provided [RCV000714264] | Chr2:40608411..146900718 [GRCh37] Chr2:2p22.1-q22.3 |
likely pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3 | copy number gain | not provided [RCV000752802] | Chr2:14238..243048760 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q21.1(chr2:131991166-132234986)x3 | copy number gain | not provided [RCV000753128] | Chr2:131991166..132234986 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3 | copy number gain | not provided [RCV000752804] | Chr2:15672..243101834 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q21.1(chr2:131947586-132307088)x3 | copy number gain | not provided [RCV000753127] | Chr2:131947586..132307088 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q21.1(chr2:132077379-132298468)x3 | copy number gain | not provided [RCV000753130] | Chr2:132077379..132298468 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q21.1(chr2:132221814-132248584)x1 | copy number loss | not provided [RCV000753132] | Chr2:132221814..132248584 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q21.1(chr2:131441725-132267790)x3 | copy number gain | not provided [RCV000845735] | Chr2:131441725..132267790 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1(chr2:131463331-132249175)x3 | copy number gain | not provided [RCV000753124] | Chr2:131463331..132249175 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q21.1(chr2:132077379-132276359)x1 | copy number loss | not provided [RCV000753129] | Chr2:132077379..132276359 [GRCh37] Chr2:2q21.1 |
benign |
GRCh37/hg19 2q21.1(chr2:131477947-132280823)x1 | copy number loss | not provided [RCV001005317] | Chr2:131477947..132280823 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1122C>T (p.Ala374=) | single nucleotide variant | not provided [RCV000882563] | Chr2:131482617 [GRCh38] Chr2:132240190 [GRCh37] Chr2:2q21.1 |
benign |
NM_080386.4(TUBA3D):c.910A>G (p.Lys304Glu) | single nucleotide variant | Inborn genetic diseases [RCV003245365] | Chr2:131480603 [GRCh38] Chr2:132238176 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1-21.2(chr2:130916858-134213436)x3 | copy number gain | not provided [RCV000846479] | Chr2:130916858..134213436 [GRCh37] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh37/hg19 2q21.1(chr2:131452092-132269288)x3 | copy number gain | not provided [RCV000846095] | Chr2:131452092..132269288 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1169G>A (p.Arg390His) | single nucleotide variant | Inborn genetic diseases [RCV003247361] | Chr2:131482664 [GRCh38] Chr2:132240237 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1264C>T (p.Arg422Cys) | single nucleotide variant | not provided [RCV000907755] | Chr2:131482759 [GRCh38] Chr2:132240332 [GRCh37] Chr2:2q21.1 |
likely benign |
NM_080386.4(TUBA3D):c.309C>T (p.Tyr103=) | single nucleotide variant | not provided [RCV000974925] | Chr2:131479390 [GRCh38] Chr2:132236963 [GRCh37] Chr2:2q21.1 |
likely benign |
NM_080386.4(TUBA3D):c.341T>A (p.Ile114Asn) | single nucleotide variant | not provided [RCV000974926] | Chr2:131479422 [GRCh38] Chr2:132236995 [GRCh37] Chr2:2q21.1 |
benign |
NM_080386.4(TUBA3D):c.4-9T>G | single nucleotide variant | not provided [RCV000970951] | Chr2:131478155 [GRCh38] Chr2:132235728 [GRCh37] Chr2:2q21.1 |
likely benign |
GRCh37/hg19 2q14.3-21.2(chr2:122952356-133826358)x1 | copy number loss | See cases [RCV001194541] | Chr2:122952356..133826358 [GRCh37] Chr2:2q14.3-21.2 |
likely pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373) | copy number gain | Mosaic trisomy 2 [RCV002280628] | Chr2:1..243199373 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q13-22.3(chr2:111484468-146333604)x3 | copy number gain | not provided [RCV001832896] | Chr2:111484468..146333604 [GRCh37] Chr2:2q13-22.3 |
pathogenic |
GRCh37/hg19 2q14.3-22.2(chr2:122699106-143799629)x1 | copy number loss | not provided [RCV001832883] | Chr2:122699106..143799629 [GRCh37] Chr2:2q14.3-22.2 |
pathogenic |
GRCh37/hg19 2q13-22.3(chr2:112475655-145691999)x3 | copy number gain | 2q13q22.3 microduplication syndrome [RCV002226436] | Chr2:112475655..145691999 [GRCh37] Chr2:2q13-22.3 |
pathogenic |
GRCh37/hg19 2q21.1-21.2(chr2:131853044-133195255)x3 | copy number gain | See cases [RCV002292205] | Chr2:131853044..133195255 [GRCh37] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh37/hg19 2q21.1(chr2:131974176-132269102)x1 | copy number loss | not provided [RCV002474806] | Chr2:131974176..132269102 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1-21.2(chr2:132058665-133163759)x3 | copy number gain | not provided [RCV002472400] | Chr2:132058665..133163759 [GRCh37] Chr2:2q21.1-21.2 |
uncertain significance |
NM_080386.4(TUBA3D):c.466C>T (p.Arg156Trp) | single nucleotide variant | Hepatocellular carcinoma [RCV002302737] | Chr2:131480159 [GRCh38] Chr2:132237732 [GRCh37] Chr2:2q21.1 |
pathogenic |
NM_080386.4(TUBA3D):c.430G>A (p.Gly144Ser) | single nucleotide variant | Inborn genetic diseases [RCV002882365] | Chr2:131480123 [GRCh38] Chr2:132237696 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1(chr2:131974176-132280823)x1 | copy number loss | not provided [RCV002475825] | Chr2:131974176..132280823 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1267G>A (p.Glu423Lys) | single nucleotide variant | Inborn genetic diseases [RCV002759919] | Chr2:131482762 [GRCh38] Chr2:132240335 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.758C>T (p.Thr253Met) | single nucleotide variant | Inborn genetic diseases [RCV002758675] | Chr2:131480451 [GRCh38] Chr2:132238024 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1093G>A (p.Gly365Arg) | single nucleotide variant | Inborn genetic diseases [RCV002977927] | Chr2:131482588 [GRCh38] Chr2:132240161 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.656T>C (p.Ile219Thr) | single nucleotide variant | Inborn genetic diseases [RCV002911053] | Chr2:131480349 [GRCh38] Chr2:132237922 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1103T>G (p.Leu368Arg) | single nucleotide variant | Inborn genetic diseases [RCV002641171] | Chr2:131482598 [GRCh38] Chr2:132240171 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.467G>A (p.Arg156Gln) | single nucleotide variant | Inborn genetic diseases [RCV002956312] | Chr2:131480160 [GRCh38] Chr2:132237733 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.880G>A (p.Ala294Thr) | single nucleotide variant | Inborn genetic diseases [RCV002767708] | Chr2:131480573 [GRCh38] Chr2:132238146 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.799T>A (p.Phe267Ile) | single nucleotide variant | Inborn genetic diseases [RCV002644986] | Chr2:131480492 [GRCh38] Chr2:132238065 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.158T>C (p.Phe53Ser) | single nucleotide variant | Inborn genetic diseases [RCV002808117] | Chr2:131478318 [GRCh38] Chr2:132235891 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.139G>A (p.Asp47Asn) | single nucleotide variant | Inborn genetic diseases [RCV003211934] | Chr2:131478299 [GRCh38] Chr2:132235872 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.668C>A (p.Thr223Lys) | single nucleotide variant | Inborn genetic diseases [RCV003197713] | Chr2:131480361 [GRCh38] Chr2:132237934 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1204C>T (p.Arg402Trp) | single nucleotide variant | Inborn genetic diseases [RCV003175361] | Chr2:131482699 [GRCh38] Chr2:132240272 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.1184T>C (p.Phe395Ser) | single nucleotide variant | Inborn genetic diseases [RCV003338253] | Chr2:131482679 [GRCh38] Chr2:132240252 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.598T>C (p.Cys200Arg) | single nucleotide variant | Inborn genetic diseases [RCV003358692] | Chr2:131480291 [GRCh38] Chr2:132237864 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.968T>C (p.Val323Ala) | single nucleotide variant | Inborn genetic diseases [RCV003342780] | Chr2:131480661 [GRCh38] Chr2:132238234 [GRCh37] Chr2:2q21.1 |
uncertain significance |
NM_080386.4(TUBA3D):c.998C>T (p.Ala333Val) | single nucleotide variant | Inborn genetic diseases [RCV003354318] | Chr2:131480691 [GRCh38] Chr2:132238264 [GRCh37] Chr2:2q21.1 |
uncertain significance |
GRCh37/hg19 2q21.1-21.2(chr2:131777624-134871884)x1 | copy number loss | not provided [RCV003484904] | Chr2:131777624..134871884 [GRCh37] Chr2:2q21.1-21.2 |
uncertain significance |
GRCh37/hg19 2q12.2-21.2(chr2:106755586-134302739)x1 | copy number loss | not specified [RCV003986380] | Chr2:106755586..134302739 [GRCh37] Chr2:2q12.2-21.2 |
pathogenic |
NM_080386.4(TUBA3D):c.849C>T (p.His283=) | single nucleotide variant | not provided [RCV003885750] | Chr2:131480542 [GRCh38] Chr2:132238115 [GRCh37] Chr2:2q21.1 |
likely benign |
NM_080386.4(TUBA3D):c.867C>T (p.Ala289=) | single nucleotide variant | not provided [RCV003885751] | Chr2:131480560 [GRCh38] Chr2:132238133 [GRCh37] Chr2:2q21.1 |
likely benign |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
GDB:555004 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
H2-ALPHA__6686 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
D1S3688 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | adipose tissue | appendage | entire extraembryonic component | |
High | 172 | |||||||||||||||
Medium | 4 | 7 | 17 | 12 | 19 | 12 | 12 | 7 | 8 | 24 | 255 | 21 | 1 | 4 | ||
Low | 293 | 87 | 188 | 122 | 443 | 120 | 249 | 61 | 142 | 131 | 236 | 261 | 10 | 24 | 32 | 3 |
Below cutoff | 1153 | 1349 | 962 | 376 | 846 | 281 | 1689 | 1054 | 1670 | 206 | 541 | 757 | 99 | 426 | 1026 | 2 |
RefSeq Acc Id: | ENST00000321253 ⟹ ENSP00000326042 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000409047 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_080386 ⟹ NP_525125 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
Protein RefSeqs | NP_525125 | (Get FASTA) | NCBI Sequence Viewer |
GenBank Protein | AAA36785 | (Get FASTA) | NCBI Sequence Viewer |
AAH57810 | (Get FASTA) | NCBI Sequence Viewer | |
BAF84942 | (Get FASTA) | NCBI Sequence Viewer | |
CBH19489 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000326042 | ||
ENSP00000326042.6 | |||
GenBank Protein | P0DPH8 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_525125 ⟸ NM_080386 |
- UniProtKB: | Q6PEY3 (UniProtKB/Swiss-Prot), Q5W099 (UniProtKB/Swiss-Prot), P0DPH8 (UniProtKB/Swiss-Prot), P0DPH7 (UniProtKB/Swiss-Prot), A6NJQ0 (UniProtKB/Swiss-Prot), Q96F18 (UniProtKB/Swiss-Prot), Q13748 (UniProtKB/Swiss-Prot), Q1ZYQ1 (UniProtKB/TrEMBL), A8JZY9 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | ENSP00000326042 ⟸ ENST00000321253 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-P0DPH8-F1-model_v2 | AlphaFold | P0DPH8 | 1-450 | view protein structure |
RGD ID: | 6861590 | ||||||||
Promoter ID: | EPDNEW_H3960 | ||||||||
Type: | initiation region | ||||||||
Name: | TUBA3D_1 | ||||||||
Description: | tubulin alpha 3d | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:24071 | AgrOrtholog |
COSMIC | TUBA3D | COSMIC |
Ensembl Genes | ENSG00000075886 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000321253 | ENTREZGENE |
ENST00000321253.7 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 1.10.287.600 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
3.30.1330.20 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
3.40.50.1440 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
GTEx | ENSG00000075886 | GTEx |
HGNC ID | HGNC:24071 | ENTREZGENE |
Human Proteome Map | TUBA3D | Human Proteome Map |
InterPro | Alpha_tubulin | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Tub_FtsZ_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin/FtsZ_2-layer-sand-dom | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin/FtsZ_C_sf | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin/FtsZ_GTPase_sf | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin_CS | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Tubulin_FtsZ_GTPase | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
KEGG Report | hsa:113457 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
hsa:7278 | UniProtKB/TrEMBL | |
NCBI Gene | 113457 | ENTREZGENE |
OMIM | 617878 | OMIM |
PANTHER | PTHR11588 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
TUBULIN ALPHA-1B CHAIN | UniProtKB/TrEMBL | |
TUBULIN ALPHA-3C CHAIN-RELATED | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Tubulin | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Tubulin_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
PharmGKB | PA162407361 | PharmGKB |
PRINTS | ALPHATUBULIN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
TUBULIN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
PROSITE | TUBULIN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
SMART | Tubulin | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Tubulin_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Superfamily-SCOP | SSF52490 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
SSF55307 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
UniProt | A6NJQ0 | ENTREZGENE |
A8JZY9 | ENTREZGENE, UniProtKB/TrEMBL | |
P0DPH7 | ENTREZGENE | |
P0DPH8 | ENTREZGENE | |
Q13748 | ENTREZGENE | |
Q1ZYQ1 | ENTREZGENE, UniProtKB/TrEMBL | |
Q5W099 | ENTREZGENE | |
Q6PEY3 | ENTREZGENE | |
Q96F18 | ENTREZGENE | |
TBA3D_HUMAN | UniProtKB/Swiss-Prot | |
UniProt Secondary | A6NJQ0 | UniProtKB/Swiss-Prot |
Q13748 | UniProtKB/Swiss-Prot | |
Q5W099 | UniProtKB/Swiss-Prot | |
Q6PEY3 | UniProtKB/Swiss-Prot | |
Q96F18 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2015-12-15 | TUBA3D | tubulin alpha 3d | tubulin, alpha 3d | Symbol and/or name change | 5135510 | APPROVED | |
2011-10-11 | TUBA3D | tubulin, alpha 3d | TUBA3D | tubulin, alpha 3d | Symbol and/or name change | 5135510 | APPROVED |